Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

Shionogi’s S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao ...

Jake Sullivan, the outgoing national security adviser, is asking a panel of outside experts to examine the government’s ...

Four countries reported new polio cases this week, with onsets in late 2024, according to the weekly update from the Global ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to study findings.

Vaccination prior to COVID-19 infection does not significantly affect neurological symptoms in patients with postacute sequelae of SARS-CoV-2 infection.

Adriel Chen and Devi Sridhar discuss the outbreak of Paediatric Inflammatory Multisystem Syndrome in 2020 and consider what lessons we can learn In mid-March 2020 and into April 2020, paediatric wards ...

According to the researchers, Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating condition that is ...

A recent University of Utah Health study found that 4.5% of Covid-19 survivors developed chronic fatigue syndrome, a ...